Pharmacy reimbursement in the United States is still governed by legacy payment structures shaped decades ago, long before specialty drugs, PBMs, and value-based care dominated healthcare economics. These models emphasize drug dispensing rather than clinical contribution, creating mounting pressure on independent and community pharmacies.

As payer complexity increases and reimbursement transparency declines, pharmacies are increasingly forced to rethink revenue cycle management strategies to survive. Understanding how these outdated structures work and where they fail is now essential for long-term sustainability.

> Origins of Legacy Pharmacy Reimbursement Models

Traditional pharmacy reimbursement was built on a product-centric model, where revenue depended on drug cost reimbursement plus a dispensing fee. This framework assumed stable margins and predictable payer behavior.

However, this model did not anticipate:

ο  PBM-driven price compression

ο  Narrow generic margins

ο  Expanding clinical expectations without parallel payment

Today, pharmacies must supplement dispensing revenue with optimized pharmacy services and operational efficiency to remain viable.

> Average Wholesale Price (AWP): A Flawed Benchmark

For decades, reimbursement has been tied to Average Wholesale Price (AWP) minus a payer-negotiated percentage, plus a dispensing fee. However, AWP does not reflect true acquisition cost and is widely criticized as a benchmark.

Authoritative reviews have highlighted that AWP-based reimbursement often results in pharmacies being paid below acquisition cost, especially for generics.

This disconnect directly impacts accounts receivable performance and cash flow predictability.

> Dispensing Fees: Static Payments in a Dynamic Market

Dispensing fees were intended to offset operational costs such as staffing, inventory handling, compliance, and counseling. However, these fees have not kept pace with inflation or regulatory burden.

Key challenges include:

ο  Flat fees despite rising labor costs

ο  No differentiation for service complexity

ο  Increased reporting without increased reimbursement

As a result, pharmacies are increasingly dependent on optimized medical billing workflows to reduce revenue leakage.

> The Role of Pharmacy Benefit Managers (PBMs)

Pharmacy Benefit Managers exert significant control over reimbursement through pricing formulas, formulary decisions, and network access. Their revenue model often relies on spread pricing and retroactive fees.

The Federal Trade Commission (FTC) has raised concerns regarding PBM market concentration and pricing transparency.

PBM-dictated reimbursement places additional strain on pharmacy payer’s relationships and contract negotiations.

> Direct & Indirect Remuneration (DIR) Fees: Retrospective Risk

DIR fees were designed as performance incentives but have evolved into retrospective clawbacks applied months after dispensing.

CMS has acknowledged the destabilizing impact of DIR fees on pharmacy cash flow.

For pharmacies, this creates volatility in accounts receivable and makes revenue forecasting difficult.

> Lack of Recognition for Clinical Pharmacy Services

Pharmacists now provide immunizations, MTM, chronic disease monitoring, and preventive care, yet legacy reimbursement models still classify pharmacies as product vendors.

Industry groups such as the National Association of Chain Drug Stores (NACDS) continue to advocate for recognition of provider status.

Until reimbursement structures evolve, pharmacies must rely on operational support, including virtual medical assistant services and optimized front desk management to control overhead.

> Regulatory Pressure & State-Level Interventions

State and federal regulators are increasingly scrutinizing PBM practices, pricing transparency, and network fairness. While reforms have introduced reporting requirements, they have not fully replaced outdated reimbursement benchmarks.

This fragmented regulatory environment makes credentialing accuracy and payer compliance more important than ever.

> How Evocare Billings Helps Pharmacies Navigate Reimbursement Challenges

Evocare Billings supports pharmacies with comprehensive revenue cycle management, focusing on reimbursement analysis, payer reconciliation, and denial prevention tied to legacy payment models.

Our services extend beyond billing to include IT solutions, payer enrollment support, and workflow optimization that improve cash flow and reduce administrative burden.

By strengthening account receivable performance and payer alignment, Evocare Billings helps pharmacies adapt to modern reimbursement realities without relying solely on outdated dispensing margins.

> Conclusion

Legacy reimbursement structures were not designed for today’s pharmacy environment. As PBM influence, pricing opacity, and clinical expectations grow, reliance on outdated models places pharmacies at increasing financial risk.

Pharmacies that modernize their billing operations, payer strategy, and operational infrastructure are best positioned to remain profitable in a rapidly evolving healthcare system.

Contact us today at info@evocarebillings.com or call (323) 412-5399 to explore how we can help your practice grow with smarter, more efficient billing solutions.